These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25175335)

  • 1. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
    Giguère Y; Massé J; Thériault S; Bujold E; Lafond J; Rousseau F; Forest JC
    BJOG; 2015 Feb; 122(3):402-10. PubMed ID: 25175335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pregnancy screening for hypertensive disorders in women without a-priori high risk.
    Abdelaziz A; Maher MA; Sayyed TM; Bazeed MF; Mohamed NS
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):398-405. PubMed ID: 22689569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OS090. Performance of candidate clinical and biochemical markers in screening early in pregnancy to detect women at high risk to develop preeclampsia.
    Forest JC; Massé J; Bujold E; Rousseau F; Charland M; Thériault S; Lafond J; Giguère Y
    Pregnancy Hypertens; 2012 Jul; 2(3):227. PubMed ID: 26105305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation.
    Panaitescu AM; Wright D; Militello A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):383-387. PubMed ID: 28133834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.
    Youssef A; Righetti F; Morano D; Rizzo N; Farina A
    Prenat Diagn; 2011 Dec; 31(12):1141-6. PubMed ID: 22034048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
    Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
    Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):671-9. PubMed ID: 20069559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
    Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation.
    Andrietti S; Silva M; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jul; 48(1):72-9. PubMed ID: 26566592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PP054. Predicting preeclampsia at late mid-term pregnancy before occurrence of clinical symptoms: Clinical utility of biomarkers and clinical parameters in a low-risk population.
    Forest JC; Massé J; Bujold E; Lafond J; Charland M; Rousseau F; Giguère Y
    Pregnancy Hypertens; 2012 Jul; 2(3):271. PubMed ID: 26105377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.
    Rohra DK; Zeb A; Qureishi RN; Azam SI; Khan NB; Zuberi HS; Sikandar R
    Natl Med J India; 2012; 25(2):68-73. PubMed ID: 22686711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.